- Report
- May 2024
- 136 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Clinical Trials
- April 2025
- 150 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- July 2024
- 207 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 206 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- May 2024
- 160 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- February 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP

Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more